$DWAY
Driveitaway Holdings, Inc. Stock $dway

$dway Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000173112222001479 Filed on August 24, 2022

Income Statement

Concept	2022 Q3	2022 Q1	2021 Q4
Revenue	$26.78K	$11.03K	$374.0K
YoY Change	-89.92%	-70.17%	-50.6%
Cost Of Revenue	$17.11K	$5.409K	$41.30K
YoY Change	-74.35%	-49.74%	-53.04%
Gross Profit	$9.670K	$5.620K	$332.7K
YoY Change	-95.14%	-78.56%	-50.28%
Gross Profit Margin	36.11%	50.96%	88.96%
Selling, General & Admin	$234.9K	$19.71K	$317.4K
YoY Change	-241.18%	32.54%	-23.75%
% of Gross Profit	2429.37%	350.75%	95.42%
Research & Development	$15.72K	$13.71K	$15.68K
YoY Change		-11.79%
% of Gross Profit	162.56%	243.88%	4.71%
Depreciation & Amortization	$8.440K		$27.32K
YoY Change	-70.57%		-12.58%
% of Gross Profit	87.28%		8.21%
Operating Expenses	$250.6K	$346.7K	$344.8K
YoY Change	64.58%	168.38%	-22.97%
Operating Profit	-$241.0K	-$341.1K	-$12.07K
YoY Change	-617.53%	231.24%	-105.45%
Interest Expense	$401.8K	-$12.33K	-$6.900K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$98.95K	-$500.0K	-$300.00
YoY Change	-3477.13%	22731.87%	-115.38%
Pretax Income	$259.8K	-$841.1K	-$12.37K
YoY Change	495.46%	699.83%	-105.54%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$259.8K	-$841.1K	-$251.7K
YoY Change	495.46%	699.83%	154.88%
Net Earnings / Revenue	970.13%	-7626.13%	-67.31%
Basic Earnings Per Share		-$0.12
Diluted Earnings Per Share	$0.00	-$118.7K	-$938.80
COMMON SHARES
Basic Shares Outstanding	105.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$127.1K	$593.1K	$278.9K
YoY Change	-63.67%	50.79%	-38.55%
Cash & Equivalents	$127.1K	$593.1K	$6.066K
Short-Term Investments
Other Short-Term Assets	$10.50K		$183.7K
YoY Change	-94.52%		-16.41%
Inventory
Prepaid Expenses	$10.50K
Receivables	$6.082K	$9.324K	$52.58K
Other Receivables	$0.00	$100.0K	$5.850K
Total Short-Term Assets	$143.7K	$702.4K	$521.0K
YoY Change	360.11%	-16.56%	-42.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$149.4K		$103.9K
YoY Change	478.51%		3.37%
Goodwill		$1.557M
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets			$234.5K
YoY Change			-46.7%
Total Long-Term Assets	$149.4K	$1.557M	$492.4K
YoY Change		245.91%	-8.91%
TOTAL ASSETS
Total Short-Term Assets	$143.7K	$702.4K	$521.0K
Total Long-Term Assets	$149.4K	$1.557M	$492.4K
Total Assets	$293.1K	$2.259M	$1.013M
YoY Change	838.61%	74.89%	-29.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$198.1K	$60.26K	$57.86K
YoY Change	17.31%	5.42%	-14.26%
Accrued Expenses	$29.04K	$42.96K	$428.2K
YoY Change	157.92%	90.19%	1795.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$120.0K
YoY Change	-100.0%	-100.0%	0.0%
Long-Term Debt Due	$755.8K	$393.7K
YoY Change
Total Short-Term Liabilities	$1.100M	$501.0K	$1.314M
YoY Change	379.93%	-48.97%	25.39%
LONG-TERM LIABILITIES
Long-Term Debt	$292.2K	$505.3K	$0.00
YoY Change
Other Long-Term Liabilities			$1.110M
YoY Change			-44.1%
Total Long-Term Liabilities	$292.2K	$505.3K	$1.110M
YoY Change	-77.02%	-70.15%	-44.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.100M	$501.0K	$1.314M
Total Long-Term Liabilities	$292.2K	$505.3K	$1.110M
Total Liabilities	$1.392M	$606.2K	$2.425M
YoY Change	169.52%	-77.33%	-20.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.381M	-$1.998M
YoY Change	162.95%
Common Stock	$1.300M	$3.269M
YoY Change	209.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.13K
YoY Change
Treasury Stock Shares	15.10K shares	15.10K shares
Shareholders Equity	-$1.099M	$1.253M	-$564.0K
YoY Change
Total Liabilities & Shareholders Equity	$293.1K	$2.259M	$1.013M
YoY Change	838.61%	74.89%	-29.68%

Cashflow Statement

Concept	2022 Q3	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$259.8K	-$841.1K	-$251.7K
YoY Change	495.46%	699.83%	154.88%
Depreciation, Depletion And Amortization	$8.440K		$27.32K
YoY Change	-70.57%		-12.58%
Cash From Operating Activities	-$827.6K	-$217.3K	-$72.25K
YoY Change	4797.1%	255.61%	-425.45%
INVESTING ACTIVITIES
Capital Expenditures	$157.9K		-$630.00
YoY Change	-969.27%		270.59%
Acquisitions
YoY Change
Other Investing Activities	$70.36K	$70.36K	$0.00
YoY Change	8377.11%	8377.11%	-100.0%
Cash From Investing Activities	-$87.50K	$70.99K	-$630.00
YoY Change	404.9%	-3649.5%	-195.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.032M	802.5K	$136.2K
YoY Change
NET CHANGE
Cash From Operating Activities	-827.6K	-217.3K	-72.25K
Cash From Investing Activities	-87.50K	70.99K	-630.0
Cash From Financing Activities	1.032M	802.5K	$136.2K
Net Change In Cash	117.3K	656.2K	-72.88K
YoY Change	-442.8%	-1139.87%	-418.81%
FREE CASH FLOW
Cash From Operating Activities	-$827.6K	-$217.3K	-$72.25K
Capital Expenditures	$157.9K		-$630.00
Free Cash Flow	-$985.5K		-$71.62K
YoY Change	-78311.9%		-420.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	clcn	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001394638
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2021Q3	us-gaap	Goodwill Goodwill		usd
CY2022Q1	clcn	Ppp Loan PppLoan		usd
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent		usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue		usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness		usd
	clcn	Loss On Contingency Liability LossOnContingencyLiability		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest		usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	clcn	Preferred Stock Issued For Conversion Of Debt Related Parties PreferredStockIssuedForConversionOfDebtRelatedParties		usd
	clcn	Preferred Stock Issued For Conversion Of Debt PreferredStockIssuedForConversionOfDebt		usd
	clcn	Common Stock And Warrant Issued In Connection With Promissory Note CommonStockAndWarrantIssuedInConnectionWithPromissoryNote		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-52883
	dei	Entity Registrant Name EntityRegistrantName	DRIVEITAWAY HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4456503
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 Market Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200/201
	dei	Entity Address City Or Town EntityAddressCityOrTown	Philadelphia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19104
	dei	City Area Code CityAreaCode	(856)
	dei	Local Phone Number LocalPhoneNumber	577-2763
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105286622	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	593059	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9774	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9324	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21455	usd
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	100000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	702383	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	31229	usd
CY2022Q1	us-gaap	Goodwill Goodwill	1557106	usd
CY2022Q1	us-gaap	Assets Assets	2259489	usd
CY2021Q3	us-gaap	Assets Assets	31229	usd
CY2022Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	60264	usd
CY2021Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	150821	usd
CY2022Q1	srt	Bank Loans BankLoans	9431	usd
CY2021Q3	srt	Bank Loans BankLoans	6128	usd
CY2021Q3	clcn	Ppp Loan PppLoan	23750	usd
CY2022Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	4081	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	7268	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42964	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11261	usd
CY2021Q3	clcn	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	30000	usd
CY2022Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	384237	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	500977	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	229228	usd
CY2022Q1	clcn	Sba Loan Noncurrent SbaLoanNoncurrent	105269	usd
CY2021Q3	clcn	Sba Loan Noncurrent SbaLoanNoncurrent	72372	usd
CY2021Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	150000	usd
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	65000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	606246	usd
CY2021Q3	us-gaap	Liabilities Liabilities	516600	usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	400000	usd
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2594593	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2594593	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2300000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2300000	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	259	usd
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	230	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17716041	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17700941	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1772	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3267539	usd
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	419793	usd
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	15100	shares
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2022Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	18126	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1998201	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-905394	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1253243	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-485371	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2259489	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31229	usd
CY2022Q1	us-gaap	Revenues Revenues	11029	usd
CY2021Q1	us-gaap	Revenues Revenues	36974	usd
	us-gaap	Revenues Revenues	21646	usd
	us-gaap	Revenues Revenues	61365	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5409	usd
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10762	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11095	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20355	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	5620	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	26212	usd
	us-gaap	Gross Profit GrossProfit	10551	usd
	us-gaap	Gross Profit GrossProfit	41010	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	119950	usd
CY2021Q1	us-gaap	Salaries And Wages SalariesAndWages	40578	usd
	us-gaap	Salaries And Wages SalariesAndWages	190075	usd
	us-gaap	Salaries And Wages SalariesAndWages	101051	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	193320	usd
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	58192	usd
	us-gaap	Professional Fees ProfessionalFees	366397	usd
	us-gaap	Professional Fees ProfessionalFees	58477	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17163	usd
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14707	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29846	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31239	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13706	usd
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15538	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29385	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47672	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	2549	usd
CY2021Q1	us-gaap	Selling Expense SellingExpense	165	usd
	us-gaap	Selling Expense SellingExpense	4889	usd
	us-gaap	Selling Expense SellingExpense	2380	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	346688	usd
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	129180	usd
	us-gaap	Operating Expenses OperatingExpenses	620592	usd
	us-gaap	Operating Expenses OperatingExpenses	240819	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-341068	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-102968	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-610041	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-199809	usd
CY2022Q1	clcn	Loss On Contingency Libility LossOnContingencyLibility	400000	usd
	clcn	Loss On Contingency Libility LossOnContingencyLibility	400000	usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness	-24148	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	87683	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	87683	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	11481	usd
CY2021Q1	us-gaap	Interest Expense Other InterestExpenseOther	784	usd
	us-gaap	Interest Expense Other InterestExpenseOther	16940	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1586	usd
CY2022Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	859	usd
CY2021Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	1406	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2296	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2522	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	5	usd
	us-gaap	Interest Income Other InterestIncomeOther	5	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-500018	usd
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2190	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-482766	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4108	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-841086	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105158	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1092807	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-203917	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-841086	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-105158	usd
	us-gaap	Profit Loss ProfitLoss	-1092807	usd
	us-gaap	Profit Loss ProfitLoss	-203917	usd
CY2022Q1	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.12
	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.31
CY2022Q1	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding	7086416	shares
	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding	3504272	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-485371	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	173077	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-251721	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-564015	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	115384	usd
CY2022Q1	clcn	Preferred Stock Issued For Conversion Of Debt Related Party PreferredStockIssuedForConversionOfDebtRelatedParty	104564	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	288458	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84375	usd
CY2022Q1	clcn	Reorganization Reorganization	1720867	usd
CY2022Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	344696	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-841086	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1253243	usd
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-219100	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-98759	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-317859	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	57693	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-105158	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-365324	usd
	us-gaap	Profit Loss ProfitLoss	-1092807	usd
	us-gaap	Profit Loss ProfitLoss	-203917	usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness	-24148	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	372836	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	57693	usd
	clcn	Loss On Contingency Liability LossOnContingencyLiability	400000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	87683	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12131	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-897	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	6377	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2521	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-90557	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	56298	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	38959	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8302	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-289526	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-78206	usd
	clcn	Acquisition Of Subsidiary AcquisitionOfSubsidiary	-70361	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	70361	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	65000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	766250	usd
	clcn	Proceeds From Sba Loan ProceedsFromSbaLoan	36200	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	802450	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	583285	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13206	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9774	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28975	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	593059	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15769	usd
	clcn	Preferred Stock Issued For Conversion Of Debt Related Parties PreferredStockIssuedForConversionOfDebtRelatedParties	104564	usd
	clcn	Preferred Stock Issued For Conversion Of Debt PreferredStockIssuedForConversionOfDebt	288458	usd
	clcn	Common Stock And Warrant Issued In Connection With Promissory Note CommonStockAndWarrantIssuedInConnectionWithPromissoryNote	344696	usd
	clcn	Number Of Shares Exchaged NumberOfSharesExchaged	2594593	shares
CY2022Q1	clcn	Convertible Preferred Stock ConvertiblePreferredStock	1720867	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	70361	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	100000	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	6600	usd
CY2022Q1	us-gaap	Goodwill Goodwill	1557106	usd
	clcn	Increase In Cash From Financings IncreaseInCashFromFinancings	802450	usd
	clcn	Increase In Cash From Acquisition Of Subsidiary IncreaseInCashFromAcquisitionOfSubsidiary	70361	usd
CY2019Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.06	pure
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_845_eus-gaap--FiscalPeriod_zyC7FDRzzwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_86B_z4YPaBU8iVx6">Fiscal year</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates on a September 30 fiscal year-end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zLGDMpfEBMVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zAo81aYb31se">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates and assumptions made by management include allowance for doubtful accounts, allowance for deferred tax assets, fair value of equity instruments. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q1	us-gaap	Cash Cash	593059	usd
CY2021Q3	us-gaap	Cash Cash	9774	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	300000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2022Q1	clcn	Shares Issued For Promissory Note Value SharesIssuedForPromissoryNoteValue	750000	usd
CY2022Q1	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber	1000000	shares
CY2022Q1	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue	0.30
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	28372	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2019Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1000000	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2296	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2522	usd
CY2022Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	104564	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	52284	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	90968474	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	78401540	shares
	us-gaap	Profit Loss ProfitLoss	-1092807	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	289526	usd
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-04-20
	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.15	pure
	clcn	Note Issued For Cancellation Of Common Stock NoteIssuedForCancellationOfCommonStock	500000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Preferred Stock Redemption Terms PreferredStockRedemptionTerms	The Series A Preferred Stock is entitled to receive, prior to any distribution to any junior class of securities, an amount equal to $0.01 per share as a liquidation preference before any distribution may be made to the holders of any junior security, including the Common Stock.
	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	Each holder of Series A Preferred Stock shall vote with holders of the Common Stock upon any matter submitted to a vote of shareholders, in which event it shall have the number of votes equal to the number of shares of Common Stock into which such share of Series A Preferred Stock would be convertible on the record date for the vote or consent of shareholders. Each holder of Series A Preferred Stock shall also be entitled to one vote per share on each submitted to a class vote of the holders of Series A Preferred Stock.
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Each share of Series A Preferred Stock is convertible into 33.94971 shares of Common Stock at the option of the holder thereof.
	clcn	Mandatory Conversion Right Description MandatoryConversionRightDescription	The Company has the right to convert each share of Series A Preferred Stock into 33.94971 shares of Common Stock at any time that there are less than 200,000 shares of Series A Preferred Stock outstanding.
	clcn	Stockbased Compensation Expense StockbasedCompensationExpense	288461	usd
	clcn	Stockbased Compensation Expense StockbasedCompensationExpense	57693	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	52284	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	104564	usd
	clcn	Stock Issued During Period Share Conversion Of Convertible Securities StockIssuedDuringPeriodShareConversionOfConvertibleSecurities	129809	shares
	clcn	Stock Issued For Conversion Of Debt Value StockIssuedForConversionOfDebtValue	288458	usd
	clcn	Stock Issued During Period Share Stock Options Exercised StockIssuedDuringPeriodShareStockOptionsExercised	112500	shares
CY2022Q1	clcn	Reorganization Reorganization	1720867	usd
CY2022Q1	clcn	Shares Issued For Commitment Fees SharesIssuedForCommitmentFees	4000000	shares
CY2022Q1	clcn	Shares Issued For Commitment Fees Value SharesIssuedForCommitmentFeesValue	316324	usd
CY2022Q1	clcn	Shares Issued For Promissory Note Value SharesIssuedForPromissoryNoteValue	750000	usd
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17716041	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	15100	shares
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2022Q1	us-gaap	Share Price SharePrice	0.10
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.20	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0184	pure
CY2022Q1	clcn	Reorganizations Shares ReorganizationsShares	1882793	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q3	clcn	Shares Issued For Commitment Fees SharesIssuedForCommitmentFees	2000000	shares
CY2022Q3	clcn	Shares Issued For Commitment Fees Value SharesIssuedForCommitmentFeesValue	400000	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	28372	usd
CY2021Q3	us-gaap	Convertible Debt ConvertibleDebt	2000000	usd
	us-gaap	Interest Expense InterestExpense	4833	usd

Files In Submission

Name	View Source	Status
0001731122-22-001479-index-headers.html	Edgar Link	pending
0001731122-22-001479-index.html	Edgar Link	pending
0001731122-22-001479.txt	Edgar Link	pending
0001731122-22-001479-xbrl.zip	Edgar Link	pending
clcn-20220331.xsd	Edgar Link	pending
e4009_10-q.htm	Edgar Link	pending
e4009_ex31-1.htm	Edgar Link	pending
e4009_ex31-2.htm	Edgar Link	pending
e4009_ex32-1.htm	Edgar Link	pending
e4009_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
clcn-20220331_lab.xml	Edgar Link	unprocessable
clcn-20220331_cal.xml	Edgar Link	unprocessable
clcn-20220331_pre.xml	Edgar Link	unprocessable
clcn-20220331_def.xml	Edgar Link	unprocessable
e4009_10-q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DWAY
Driveitaway Holdings, Inc. Stock $dway

2022 Q3 Form 10-Q Financial Statement

#000173112222001479 Filed on August 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DWAY Driveitaway Holdings, Inc. Stock $dway

2022 Q3 Form 10-Q Financial Statement

#000173112222001479 Filed on August 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DWAY
Driveitaway Holdings, Inc. Stock $dway